Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71257 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Etze Chotzoglou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Continuous Positive Airway Pressure, Respiratory Distress Syndrome, Newborn, Respiratory Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
In October 2018, a respiratory care protocol (RCP) including less invasive surfactant administration (LISA), was introduced for preterm infants admitted on continuous positive airway pressure (CPAP). Study Design We compared respiratory care practices and outcomes of ≥ 35‐week gestational age (GA) infants between a pre‐RCP (Jan 2016 to September 2018) and a post‐RCP cohort (Oct 2018 to Dec 2021). Infants requiring < 24 h of CPAP and diagnosed with meconium aspiration syndrome were excluded.
Results
Of the 260 infants meeting inclusion criteria, 126 belonged to the pre‐RCP and 134 to post‐RCP cohort. Compared to pre‐RCP, a lower proportion of infants in the post‐RCP received CPAP on admission but a higher proportion received surfactant therapy (8% vs 22%, p < 0.001). Notably, surfactant therapy was associated with lower FiO 2 requirement for 24 h and respiratory severity score for 48 h in the post‐RCP cohort. However, there was no difference in any of the outcomes such as the need for mechanical ventilation, incidence of pneumothorax and length of hospital stay between two cohorts.
Conclusions
Implementing an RCP increased surfactant use with associated improvement in oxygenation but did not improve outcomes. Further studies are necessary to evaluate the role of LISA in ≥ 35‐week GA infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
- Parkland Health and Hospital System, Dallas, Texas.
- Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
ORCID-Profile: Arun Prasath
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Chotzoglou, E., Prasath, A., Desai, R., David, L., Ornelas, N., Burchfield, P., Brown, L. S., Nelson, D. B., & Kakkilaya, V. (2025). Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71257
Vancouver
Chotzoglou E, Prasath A, Desai R, David L, Ornelas N, Burchfield P, et al. Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71257
BibTeX
@article{Chotzoglou2025,
author = {Chotzoglou, Etze and Prasath, Arun and Desai, Riddhi and David, Lebanon and Ornelas, Nancy and Burchfield, Patti and Brown, Larry Steven and Nelson, David B and Kakkilaya, Venkatakrishna},
title = {Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71257}
}
EUVIMED